Literature DB >> 24441392

From changes in local RAAS to structural remodeling of the left atrium: A beautiful cycle in atrial fibrillation.

Q Yongjun1, S Huanzhang, Z Wenxia, T Hong, X Xijun.   

Abstract

AIMS: In earlier studies, we reported structural remodeling was associated with atrial fibrillation (AF) and showed that the renin-angiotensin-aldosterone system (RAAS) was linked to AF. It is reasonable to hypothesize that there is a cycle, from RAAS to structural remodeling to AF. PATIENTS AND METHODS: Our study group consisted of 80 patients scheduled for mitral valve replacement surgery. Tissue samples of the left atrial appendages were obtained. Masson's trichrome staining and immunohistochemical staining were performed to assess the extent of fibrosis. Radioimmunoassay was carried out to investigate the expression levels of local RAAS. RAAS-related genes were analyzed by RT-PCR.
RESULTS: There was a significantly increased degree of fibrosis in AF patients compared with sinus rhythm (SR) patients (p = 0.023). There were significant differences in the expression levels of local angiotensin (Ang) II between the SR and the AF groups (p = 0.002). The expression levels of local Ang II correlated with the duration of AF (r = 0.727851, p = 0.001) and with collagen type I (r = 0.672189, p = 0.032). In the AF group, the mRNA expressions of the AT1R and ACE genes were markedly up-regulated in comparison with the SR group (p = 0.021 and p = 0.037).
CONCLUSIONS: On the basis of this study, and in combination with results of our previous studies, we demonstrate for the first time that there is a cycle involving RAAS, structural remodeling, and AF. RAAS, structural remodeling, and AF are the principal aspects in this cycle.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24441392     DOI: 10.1007/s00059-013-4032-7

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  20 in total

1.  Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease.

Authors:  Jagmeet P Singh; Alexander Kulik; Raisa Levin; Patrick T Ellinor; Jeremy Ruskin; Jerry Avorn; Niteesh K Choudhry
Journal:  Europace       Date:  2012-04-26       Impact factor: 5.214

Review 2.  Atrial remodeling and atrial fibrillation: mechanisms and implications.

Authors:  Stanley Nattel; Brett Burstein; Dobromir Dobrev
Journal:  Circ Arrhythm Electrophysiol       Date:  2008-04

3.  Abnormalities of left atrial function after cardioversion: an atrial strain rate study.

Authors:  L Thomas; T McKay; K Byth; T H Marwick
Journal:  Heart       Date:  2006-07-03       Impact factor: 5.994

4.  The changes of serum angiotensin-converting enzyme 2 in patients with pulmonary arterial hypertension due to congenital heart disease.

Authors:  Hai-long Dai; Yue Guo; Xue-feng Guang; Zhi-cheng Xiao; Ming Zhang; Xiao-long Yin
Journal:  Cardiology       Date:  2013-03-20       Impact factor: 1.869

5.  Polymorphisms of the angiotensin-converting enzyme and angiotensinogen gene in patients with atrial fibrillation.

Authors:  Nurdan Papila Topal; Beste Ozben; Veysel Sabri Hancer; Azra Meryem Tanrikulu; Reyhan Diz-Kucukkaya; Ali Serdar Fak; Yelda Basaran; Osman Yesildag
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2011-03-24       Impact factor: 1.636

6.  Circulating and local renin-angiotensin-aldosterone system express differently in atrial fibrillation patients with different types of mitral valvular disease.

Authors:  Yongjun Qian; Ying Liu; Hong Tang; Wenxia Zhou; Lu Jiang; Yongbo Li; Ning Li; Mei Li; Xijun Xiao
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2012-10-16       Impact factor: 1.636

7.  Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation.

Authors:  Yong Li; Zhao Jian; Zong Ying Yang; Lin Chen; Xue Feng Wang; Rui Yan Ma; Ying Bin Xiao
Journal:  Cardiology       Date:  2013-04-06       Impact factor: 1.869

8.  Different structural remodelling in atrial fibrillation with different types of mitral valvular diseases.

Authors:  Yongjun Qian; Jun Meng; Hong Tang; Guo Yang; Yiling Deng; Dongming Wei; Bo Xiang; Xijun Xiao
Journal:  Europace       Date:  2010-01-26       Impact factor: 5.214

9.  Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model.

Authors:  Michiro Kiryu; Shinichi Niwano; Hiroe Niwano; Jun Kishihara; Yuya Aoyama; Hidehira Fukaya; Yoshihiko Masaki; Tohru Izumi
Journal:  Europace       Date:  2012-03-27       Impact factor: 5.214

10.  Atrial extracellular matrix remodelling in patients with atrial fibrillation.

Authors:  V Polyakova; S Miyagawa; Z Szalay; J Risteli; S Kostin
Journal:  J Cell Mol Med       Date:  2008-01-10       Impact factor: 5.310

View more
  3 in total

1.  Myeloperoxidase in atrial fibrillation: association with progression, origin and influence of renin-angiotensin system antagonists.

Authors:  Erik Holzwirth; Jelena Kornej; Sandra Erbs; Danilo Obradovic; Andreas Bollmann; Gerhard Hindricks; Holger Thiele; Petra Büttner
Journal:  Clin Res Cardiol       Date:  2019-06-24       Impact factor: 5.460

Review 2.  Nanotechnology, an alternative with promising prospects and advantages for the treatment of cardiovascular diseases.

Authors:  Tao Li; Weitao Liang; Xijun Xiao; Yongjun Qian
Journal:  Int J Nanomedicine       Date:  2018-11-09

3.  The Potential Effects of Aliskiren on Atrial Remodeling Induced by Chronic Intermittent Hypoxia in Rats.

Authors:  Shuai Miao; Yu Yang; Ruiling Li; Li Yin; Kai Zhang; Lijun Cheng; Xiaona Xu; Weiding Wang; Zhiqiang Zhao; Guangping Li
Journal:  Drug Des Devel Ther       Date:  2020-09-16       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.